| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 09/27/2007 | US20070225243 Treatment of cancer using cytokine-expressing polynucleotides and compositions therefor |
| 09/27/2007 | US20070225240 Screening Assay and Treatment |
| 09/27/2007 | US20070225239 Peptide nucleic acid conjugated to a neamine are used to prevent or treat a disease associated with an aberrant nucleic acid molecule; targets include the human immunodeficiency virus-1 genome and messenger RNA encoding angiotensis II, nuclear factor kappa, and platelet-derived growth factor |
| 09/27/2007 | US20070225231 using polypeptides that can bind specifically to the CH2-CH3 cleft of an immunoglobulin molecule to inhibit Fc-mediated immune complex formation; rheumatoid arthritis |
| 09/27/2007 | US20070225230 Vehicle for the Transport of a Chosen Molecule to a Cell |
| 09/27/2007 | US20070225228 Blockade of gamma-secretase activity to promote myelination by oligodendrocytes |
| 09/27/2007 | US20070225227 Lipoparticles comprising ion channels, methods of making and using the same |
| 09/27/2007 | US20070225226 C-reactive protein apheresis |
| 09/27/2007 | US20070225225 Use of natriuretic peptide receptor antagonists to treat ocular, otic and nasal edemetous conditions |
| 09/27/2007 | US20070225224 Modified Vitamin K-Dependent Polypeptides |
| 09/27/2007 | US20070225223 Modified Vitamin K-Dependent Polypeptides |
| 09/27/2007 | US20070225222 Use of heparin-binding domain of fibronectin for diagnosis and treatment of cancer |
| 09/27/2007 | US20070225221 Methods of treatment using specific binding agents of human angiopoietin-2 |
| 09/27/2007 | US20070225220 Antimicrobial composition |
| 09/27/2007 | US20070225219 Intramedullary drug delivery device and method of treating bone fractures |
| 09/27/2007 | US20070225218 Extracellular Messengers |
| 09/27/2007 | US20070225217 Methods, compositions, and kits for the treatment of medical conditions |
| 09/27/2007 | US20070225216 Cyclic peptides for modulating growth of neo-vessels and their use in therapeutic angiogenesis |
| 09/27/2007 | US20070225215 Modulation of Cartilage Homeostasis By Active Domains of Cell Binding Extracellular Matrix Molecules |
| 09/27/2007 | US20070225214 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 09/27/2007 | US20070225212 Use of a peptide |
| 09/27/2007 | US20070225211 Methods and Formulations for Increasing Intestinal Function |
| 09/27/2007 | US20070225210 Therapeutic vaccine compositions for the treatment of type 1 diabetes |
| 09/27/2007 | US20070225209 Compositions and methods for treating neurological disorders and diseases |
| 09/27/2007 | US20070225207 Group 1 Mite Polypeptide Variants |
| 09/27/2007 | US20070225205 Interferon-alpha polypeptides and conjugates |
| 09/27/2007 | US20070225204 Interferon-alpha polypeptides and conjugates |
| 09/27/2007 | US20070225203 Method and Composition for Preventing Multiple Organ Dysfunction Syndrome |
| 09/27/2007 | US20070224673 Proteases and Variants thereof |
| 09/27/2007 | US20070224671 Inhibitors of serine protease activity methods and compositions for treatment of nitric oxide-induced clinical conditions |
| 09/27/2007 | US20070224670 Chondroitinase ABC I and methods of production |
| 09/27/2007 | US20070224665 Using coordinate directed mutation to generate of interest; directed protein evolution |
| 09/27/2007 | US20070224663 Identifying and characterizing novel human secreted proteins and their genes ; promotes vascularization; screening methods |
| 09/27/2007 | US20070224656 Modulation of Abeta levels by beta-secretase BACE2 |
| 09/27/2007 | US20070224649 Novel scavenger receptor |
| 09/27/2007 | US20070224300 Weight loss compositions using citrus peel extract and eurycoma longfolia |
| 09/27/2007 | US20070224294 Novel non-surgical method for treating cataracts in mammals including man |
| 09/27/2007 | US20070224290 Nutrient supplements and methods for treating autism and for preventing the onset of autism |
| 09/27/2007 | US20070224284 Methods and compositions comprising at least one alpha3 beta4 nAChR antagonist or pharmaceutically acceptable salt thereof |
| 09/27/2007 | US20070224251 Hemostatic material |
| 09/27/2007 | US20070224237 Barbed sutures having a therapeutic agent thereon |
| 09/27/2007 | US20070224224 Protozoan Strains of Reduced Virulence and Use Thereof |
| 09/27/2007 | US20070224221 Botulinum toxin neurotoxic component for treating juvenile cerebral palsy |
| 09/27/2007 | US20070224212 for therapeutic treatment against HIV infection by inhibiting the virus-host cell membrane fusion process; inhibitors of HIV infectivity |
| 09/27/2007 | US20070224209 Therapeutic uses of glandular kallikrein |
| 09/27/2007 | US20070224201 Maytansinoid conjugated immunoglobulin for use in prevention, detection and treatment of cell proliferative disorders |
| 09/27/2007 | US20070224200 Gm3 Synthase as a Therapeutic Target in Microvascular Complications of Diabetes |
| 09/27/2007 | US20070224198 Antithrombotic agents |
| 09/27/2007 | US20070224194 Methods for Inhibiting Angiogenesis and/or Lymphangiogenesis |
| 09/27/2007 | US20070224193 Methods of increasing lean tissue mass using ob protein compositions |
| 09/27/2007 | US20070224186 Diagnostic methods for diseases by screening for hepcidin in human or animal tissues, blood or body fluids; monoclonal antibodies specific to human hepcidin and associated uses therefor |
| 09/27/2007 | US20070224185 Secreted and Transmembrane Polypeptides and Nucleic Acids Encoding the Same |
| 09/27/2007 | US20070224184 Method for treating cellulite |
| 09/27/2007 | US20070224183 Pure drug product consisting of collagenase I and collagenase II having the sequence of Clostridium histolyticum collagenase I and collagenase II; possibly Xiaflex (tradename) |
| 09/27/2007 | US20070224182 Therapeutic and prophylactic uses of cell specific carbonic anhydrase enzymes in treating aging disorders due to oxidative stress and as growth factors of stem cells |
| 09/27/2007 | US20070224181 inducer of hemopoietic cell differentiation and expansion for granulocytic population, thrombopoietin and pro-inflammatory cytokines; for pre-transplant priming of hematopoietic stem cells; chronic stress, autoimmune diseases, inflammation, rheumatoid arthritis, multiple sclerosis, fibromyalgia |
| 09/27/2007 | US20070224180 Use of polypeptides which have zinc metalloprotease activities and are referred to as IGS5, and polynucleotides encoding such polypeptides in therapy of various dysfunctions, disorders or diseases, particularly cardiovascular, metabolic, and neurodegenerative disorders |
| 09/27/2007 | US20070224178 Multimeric constructs |
| 09/27/2007 | US20070224174 Natural killer cell compositions and method for production of the same |
| 09/27/2007 | US20070224173 Nonexpansion Protocol for Autologous Cell-Based Therapies |
| 09/27/2007 | US20070224170 Adenovirus/Alphavirus Hybrid Vector for the Effective Administration and Expression of Therapeutic Genes in Tumour Cells |
| 09/27/2007 | US20070224167 Novel HCV inhibitor combinations and methods |
| 09/27/2007 | US20070224166 Uses of mammalian cytokine; related reagents |
| 09/27/2007 | US20070224165 Neuroprotective Effects of Gly-Pro-Glu Following Intravenous Infusion |
| 09/27/2007 | US20070224150 Growth factor for hair and skin treatment |
| 09/27/2007 | US20070224127 Cardiovascular disorders such as myocardial infarction, post-myocardial infarction remodeling, and congestive heart failure |
| 09/27/2007 | US20070224123 Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines |
| 09/27/2007 | US20070224122 Method of in vitro diagnosis which discriminates between exposure of a subject to Mycobacterium tuberculosis and vaccination with Bacille Calmette Guerin strain of Mycobacterium bovis, method comprising testing for presence of CD4 T lymphocytes that respond to MTBN4 |
| 09/27/2007 | US20070224121 Connective Tissue Growth Factor-4 |
| 09/27/2007 | US20070224119 Toxins and radionuclides coupled to IGF-1 receptor ligands for treatment of cancer |
| 09/27/2007 | US20070224118 Methods for soluble zalpha11 cytokine receptors |
| 09/27/2007 | US20070222842 Ejection Liquid, Ejection Device, Ejection Cartridge, and Method of Making Droplets From Liquid |
| 09/27/2007 | CA2680413A1 Use of gelsolin to diagnose and treat inflammatory diseases |
| 09/27/2007 | CA2647769A1 Control of intracellular target molecule by ip3 receptor-binding protein |
| 09/27/2007 | CA2647168A1 Methods for increasing the size of animals using needleless delivery constructs |
| 09/27/2007 | CA2646934A1 Methods for reducing protein aggregation |
| 09/27/2007 | CA2646589A1 Inhibition of tumour growth |
| 09/27/2007 | CA2646379A1 Method of treatment or prophylaxis inflammatory pain |
| 09/27/2007 | CA2646335A1 Pharmaceutical compositions |
| 09/27/2007 | CA2645983A1 Identification of crmp4 as a convergent regulator of axon outgrowth inhibition |
| 09/27/2007 | CA2645844A1 Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite-stimulation |
| 09/27/2007 | CA2645566A1 Pharmaceutical compositions |
| 09/27/2007 | CA2645147A1 Methods, compositions and devices for maintaining chemical balance of chlorinated water |
| 09/27/2007 | CA2644116A1 Continuous dosing regimens for neural stem cell proliferating agents and neural stem cell differentiating agents |
| 09/27/2007 | CA2643502A1 Dosing regimes for lh or hcg and epo for treatment of neurological disorders |
| 09/27/2007 | CA2642759A1 Subcutaneous implants containing a degradation-resistant polylactide polymer and a lh-rh analogue |
| 09/27/2007 | CA2641064A1 Antimicrobial protein |
| 09/26/2007 | EP1837399A1 Anticancer agent |
| 09/26/2007 | EP1837396A1 Salutaridine reductase and morphine biosynthesis |
| 09/26/2007 | EP1837345A1 Pharmaceutical compositions comprising cholesteryl-alpha-glucosyltransferase for the treatment of Helicobacteri pylori infections |
| 09/26/2007 | EP1837344A1 Tumor necrosis factor receptor-derived peptide analogues |
| 09/26/2007 | EP1837342A2 Sodium-channel alpha 1-subunit and their polypeptides and their treatment of generalised epilepsy with febrile seizures plus |
| 09/26/2007 | EP1837040A2 Drug delivery matrices to enhance wound healing |
| 09/26/2007 | EP1837034A1 Remedy for alzheimer´s disease |
| 09/26/2007 | EP1837033A1 REMEDY FOR DIABETES CONTAINING Cdk5 INHIBITOR |
| 09/26/2007 | EP1837031A1 Compositions and methods for treating diabetes |
| 09/26/2007 | EP1837017A2 Microparticles for delivery of nucleic acid |
| 09/26/2007 | EP1837014A1 Subcutaneous implants containing a degradation-resistant polylactide polymer and a LH-RH analogue |
| 09/26/2007 | EP1836906A1 Healthy food product |
| 09/26/2007 | EP1836315A2 Zebrafish heterotrimer g-protein gamma 2 subunit (gng2) |